We are excited to announce that Avance Biosciences will be an exhibitor at the upcoming 16th World ADC Conference, taking place November 3–6, 2025 in San Diego, CA
The World ADC conference is the premier global gathering focused on antibody–drug conjugates (ADCs), bringing together experts across discovery chemistry, translational science, clinical development, process and analytical development, and manufacturing. With more than 1,400 attendees and 170+ world-class speakers, this event offers unparalleled opportunities for scientific exchange and networking in the ADC field.
Advancing Analytical Excellence for ADCs
As ADCs continue to push the boundaries of targeted oncology therapeutics, robust bioanalytical and analytical support is vital. Avance Biosciences brings deep expertise in CGMP- and GLP-compliant assay development, validation, and testing, tailored to complex biologics and conjugated modalities.
Visit Our Team—Let’s Collaborate
We invite conference attendees to visit the Avance Biosciences booth to explore how our regulatory-compliant, high-fidelity testing solutions can accelerate ADC pipelines. Whether you are in discovery, translational development, or preparing for clinical and manufacturing phases, our team is eager to connect and explore synergy.
See you at World ADC – 2025!
Accelerate your drug development with Avance Biosciences’ Next-Generation Sequencing (NGS) Center of Excellence, delivering GMP- and GLP-compliant genomics solutions to power your development programs. Our capabilities include Short-read Next-gen Sequencing, Nanopore Third-gen Sequencing, PacBio Third-gen Sequencing, 10X Chromium Single-cell Sequencing, and Mission Bio Tapestri Single-cell Sequencing. Learn more at our NGS Center of Excellence and contact our experts to get started.
